Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells-Reference-Cited by-同舟云学术

Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells

Published:2017-03-07 Issue:18 Volume:8 Page:29760-29770
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wen Yan¹²,Zhao Rui-Qiang²³,Zhang Yun-Kai²,Gupta Pranav²,Fu Li-Xiang⁴,Tang An-Zhou⁵,Liu Bu-Ming⁶,Chen Zhe-Sheng²,Yang Dong-Hua²,Liang Gang⁴

Affiliation:

1. Department of Pharmacy, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, P.R. China

2. Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA

3. Department of Biochemistry and Molecular Biology, School of Preclinical Medicine, Guangxi Medical University, Nanning 530021, P.R. China

4. College of Pharmacy, Guangxi Medical University, Nanning 530021, P.R. China

5. Department of Otolaryngology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, P.R. China

6. Guangxi Key Laboratory of Traditional Chinese Medicine Quality Standards, Guangxi Institute of Chinese Medicine and Pharmaceutical Sciences, Nanning 530022, P.R. China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigallocatechin Gallate Derivative Y6 Reverses Oxaliplatin Resistance in Hepatocellular Carcinoma via Targeting the MiR-338-3p/HIF-1α/TWIST Axis to Inhibit EMT;Recent Patents on Anti-Cancer Drug Discovery;2024-07-11

2. Natural agents' role in cancer chemo-resistance prevention and treatment: molecular mechanisms and therapeutic prospects;PHARM PRACT-GRANADA;2024

3. Drug Resistance in Hepatocellular Carcinoma: Theoretical Basis and Therapeutic Aspects;Frontiers in Bioscience-Landmark;2024-02-04

4. Tea-break with epigallocatechin gallate derivatives – Powerful polyphenols of great potential for medicine;European Journal of Medicinal Chemistry;2023-12

5. Natural bioactive compounds-doxorubicin combinations targeting topoisomerase II-alpha: Anticancer efficacy and safety;Toxicology and Applied Pharmacology;2023-02